KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Divestments (2019 - 2022)

Boston Scientific's Divestments history spans 9 years, with the latest figure at $5.0 million for Q1 2022.

  • On a quarterly basis, Divestments fell 99.38% to $5.0 million in Q1 2022 year-over-year; TTM through Dec 2022 was $5.0 million, a 99.39% decrease, with the full-year FY2022 number at $5.0 million, down 99.39% from a year prior.
  • Divestments hit $5.0 million in Q1 2022 for Boston Scientific, down from $25.0 million in the prior quarter.
  • Over the last five years, Divestments for BSX hit a ceiling of $801.0 million in Q1 2021 and a floor of $5.0 million in Q1 2022.
  • Historically, Divestments has averaged $187.2 million across 4 years, with a median of $25.0 million in 2021.
  • The widest YoY moves for Divestments: up 99.38% in 2022, down 99.38% in 2022.
  • Tracing BSX's Divestments over 4 years: stood at $90.0 million in 2019, then plummeted by 83.33% to $15.0 million in 2020, then surged by 66.67% to $25.0 million in 2021, then crashed by 80.0% to $5.0 million in 2022.
  • Business Quant data shows Divestments for BSX at $5.0 million in Q1 2022, $25.0 million in Q4 2021, and $801.0 million in Q1 2021.